Fresenius SE & Co. KGaA (0OO9.IL)
IOB · EUR · Healthcare · Medical Care Facilities
€46.14 (-0.45%) as of
Key statistics
- Market cap
- 30.34B
- P/E (TTM)
- 25.49
- EPS (TTM)
- 1.81
- Dividend yield
- 3.65%
- 52-week range
- 35.13 – 52.82
- Beta
- 1.07
- Revenue (TTM)
- 41.69B
- Profit margin
- 2.40%
- Volume
- 5.23k
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Bad Homburg vor der Höhe, Germany
- Employees
- 315,233
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.